Intuitive Surgical, Inc. $ISRG Shares Sold by PKO Investment Management Joint Stock Co

PKO Investment Management Joint Stock Co decreased its position in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 50.9% in the fourth quarter, HoldingsChannel.com reports. The fund owned 14,300 shares of the medical equipment provider’s stock after selling 14,805 shares during the period. PKO Investment Management Joint Stock Co’s holdings in Intuitive Surgical were worth $8,099,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Holos Integrated Wealth LLC acquired a new position in shares of Intuitive Surgical in the fourth quarter valued at about $25,000. Newbridge Financial Services Group Inc. lifted its holdings in shares of Intuitive Surgical by 300.0% during the fourth quarter. Newbridge Financial Services Group Inc. now owns 44 shares of the medical equipment provider’s stock worth $25,000 after purchasing an additional 33 shares during the period. Greykasell Wealth Strategies Inc. purchased a new stake in Intuitive Surgical in the third quarter valued at approximately $27,000. Olistico Wealth LLC purchased a new stake in Intuitive Surgical in the fourth quarter valued at approximately $28,000. Finally, Caitlin John LLC acquired a new position in Intuitive Surgical in the 3rd quarter worth approximately $30,000. Institutional investors and hedge funds own 83.64% of the company’s stock.

Analysts Set New Price Targets

ISRG has been the subject of several research reports. Leerink Partners decreased their price objective on shares of Intuitive Surgical from $622.00 to $573.00 and set an “outperform” rating for the company in a research note on Wednesday, April 22nd. BTIG Research reiterated a “buy” rating and issued a $574.00 price objective on shares of Intuitive Surgical in a research note on Wednesday, April 22nd. Jefferies Financial Group reduced their target price on shares of Intuitive Surgical from $560.00 to $515.00 and set a “hold” rating for the company in a report on Wednesday, April 22nd. Mizuho set a $525.00 target price on shares of Intuitive Surgical and gave the company a “neutral” rating in a research report on Monday, April 13th. Finally, UBS Group lowered their price target on shares of Intuitive Surgical from $570.00 to $550.00 and set a “neutral” rating on the stock in a report on Tuesday, March 17th. Eighteen research analysts have rated the stock with a Buy rating, seven have given a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat.com, Intuitive Surgical has a consensus rating of “Moderate Buy” and an average target price of $581.91.

Insider Buying and Selling

In other news, Director Amy L. Ladd sold 500 shares of the firm’s stock in a transaction dated Tuesday, April 28th. The stock was sold at an average price of $473.46, for a total transaction of $236,730.00. Following the sale, the director directly owned 239 shares in the company, valued at $113,156.94. This trade represents a 67.66% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, SVP Mark Brosius sold 2,362 shares of Intuitive Surgical stock in a transaction dated Wednesday, March 4th. The shares were sold at an average price of $498.68, for a total value of $1,177,882.16. Following the completion of the transaction, the senior vice president owned 3,554 shares of the company’s stock, valued at approximately $1,772,308.72. This represents a 39.93% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders have sold 5,906 shares of company stock valued at $2,907,726 in the last ninety days. Company insiders own 0.60% of the company’s stock.

Intuitive Surgical Price Performance

Shares of NASDAQ ISRG opened at $457.78 on Friday. The stock has a market capitalization of $162.13 billion, a price-to-earnings ratio of 55.49, a PEG ratio of 3.67 and a beta of 1.51. Intuitive Surgical, Inc. has a 12 month low of $427.84 and a 12 month high of $603.88. The firm’s 50 day simple moving average is $474.86 and its 200-day simple moving average is $516.55.

Intuitive Surgical (NASDAQ:ISRG) last posted its earnings results on Tuesday, April 21st. The medical equipment provider reported $2.50 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.08 by $0.42. Intuitive Surgical had a net margin of 28.15% and a return on equity of 15.98%. The firm had revenue of $2.77 billion during the quarter, compared to analysts’ expectations of $2.62 billion. During the same period in the previous year, the business posted $1.81 EPS. The business’s revenue was up 23.0% compared to the same quarter last year. Analysts anticipate that Intuitive Surgical, Inc. will post 8.57 earnings per share for the current fiscal year.

Intuitive Surgical Profile

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.